Overview
Kathryn Brownlee is a Hematologist and an Oncologist in Matthews, North Carolina. Dr. Brownlee has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Posterior Fossa Tumor.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1700 Matthews Township Parkway, Matthews, NC 28105
Atrium Health Levine Cancer Institute
Ruben Mesa is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Mesa is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Myelofibrosis, Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Bone Marrow Transplant, and Splenectomy. Dr. Mesa is currently accepting new patients.
Atrium Health Levine Cancer Institute
Jonathan Levine is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Levine has been practicing medicine for over 39 years and is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Thrombocytopenia, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Gastric Lymphoma, and Bone Marrow Aspiration. Dr. Levine is currently accepting new patients.
Atrium Health Levine Cancer Institute
Mauricio Pineda is a Hematologist and an Oncologist in Concord, North Carolina. Dr. Pineda is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Thrombocytopenia, Hairy Cell Leukemia (HCL), Childhood Iron Deficiency Anemia, and Myelodysplastic Syndrome (MDS). Dr. Pineda is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Brownlee isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Brownlee isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Childhood Iron Deficiency AnemiaDr. Brownlee isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- ChoriocarcinomaDr. Brownlee isAdvanced. Learn about Choriocarcinoma.
- Iron Deficiency AnemiaDr. Brownlee isAdvanced. Learn about Iron Deficiency Anemia.
- Lung CancerDr. Brownlee isAdvanced. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Brownlee isAdvanced. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Brownlee isAdvanced. Learn about Posterior Fossa Tumor.
- Experienced
- Acute Eosinophilic PneumoniaDr. Brownlee isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Brownlee isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Brownlee isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Brownlee isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Brownlee isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Brownlee isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.